Table 1.
Pca type | Age (y) | Gleason score | Time for ADT (mo) |
---|---|---|---|
Initial Pca | 70.8 ± 10.0 | 7.0 ± 1.0 | 0 |
CRPC | 79.8 ± 2.6 | 8.2 ± 0.8 | 56.0 ± 23.6 |
ADT, androgen‐deprivation therapy; CRPC, castration‐resistant prostate cancer; PCa prostate cancer.
Pca type | Age (y) | Gleason score | Time for ADT (mo) |
---|---|---|---|
Initial Pca | 70.8 ± 10.0 | 7.0 ± 1.0 | 0 |
CRPC | 79.8 ± 2.6 | 8.2 ± 0.8 | 56.0 ± 23.6 |
ADT, androgen‐deprivation therapy; CRPC, castration‐resistant prostate cancer; PCa prostate cancer.